Trilaciclib (Standard)
Trilaciclib (Standard) is the analytical standard of Trilaciclib (HY-101467) . This product is intended for research and analytical applications. Trilaciclib (G1T28) is an orally active CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM for CDK4 and CDK6, respectively. . Trilaciclib can effectively inhibit tumor cell proliferation and reduce the hematological toxicity caused by chemotherapy. Trilaciclib attenuates apoptosis and myelosuppression induced by 5FU (HY-90006) chemotherapy[1].
Product Specifications
CAS Number
[1374743-00-6]
Target
CDK; Reference Standards
Related Pathways
Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Smiles
O=C1NCC2(N3C1=CC4=CN=C(NC5=NC=C(N6CCN(C)CC6)C=C5)N=C43)CCCCC2
Molecular Formula
C24H30N8O
Molecular Weight
446.55
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
